Table 4.

Survival data of treated patients

All patients (N = 57)Responders OR (N = 23)Nonresponders NR (N = 34)P value OR vs. NR
Median OS from surgery to DOD (months)16.4not reached8.1<0.001
Median OS from TIL to DOD (months)15.2not reached6.1<0.001
1-year survivala50% (24 of 48)79% (15 of 19)31% (9 of 29)0.003
2-year survival45% (14 of 31)71% (10 of 14)24% (4 of 17)0.012
3-year survival42% (8 of 19)78% (7 of 9)10% (1 of 10)0.005

Abbreviations: OS, overall survival; DOD, died of disease.

  • aSurvival rates were measured from the day of TIL infusion to death.